Skip to main content
Industry News
Partnership to develop SARS-CoV-2 immunodiagnostic test
4/28/2020

Leinco Technologies and Vanderbilt University Medical Center have agreed to scale up production of the latter's antibodies with the most potential to develop an immunodiagnostic test to detect SARS-CoV-2. No financial details of the deal were disclosed.

Full Story: